Company Profiles

driven by the PitchBook Platform

Anaeropharma Science

Description

Developer of novel therapeutics designed to target a hypoxic environment in solid cancers. The company's APS001F a novel therapeutic is a genetically enhanced bacteria that fight tumors and proliferate in the hypoxic core of solid tumors, where it secretes the enzyme cytosine deaminase turning a systemically administered pro-drug into a cytotoxic agent, which hollows out the tumor from the inside.

2004

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$13.2M

Latest Deal Amount

$49.8M

Total Amount Raised

Description

Developer of novel therapeutics designed to target a hypoxic environment in solid cancers. The company's APS001F a novel therapeutic is a genetically enhanced bacteria that fight tumors and proliferate in the hypoxic core of solid tumors, where it secretes the enzyme cytosine deaminase turning a systemically administered pro-drug into a cytotoxic agent, which hollows out the tumor from the inside.

Website:

www.anaeropharma.co.jp

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

4th Floor, Yaesu KH Building, 19-8, Nihonbashi Kabuto-cho, Chuo-ku Tokyo, 103-0026Japan +81 (0)33 356 1910
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Anaeropharma Science's full profile, request a free trial.

    Anaeropharma Science Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Anaeropharma Science Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    DowCorporationMinority000 0000000 0000
    Hachijuni CapitalOtherMinority000 0000000 0000
    Innovation Network Corporation of JapanPE/BuyoutMinority000 0000000 0000
    Mitsubishi UFJ CapitalVenture CapitalMinority000 0000000 0000
    Mitsui Global InvestmentVenture CapitalMinority000 0000000 0000
    Dow Corporation
    Hachijuni Capital Other
    Innovation Network Corporation of Japan PE/Buyout
    Mitsubishi UFJ Capital Venture Capital
    Mitsui Global Investment Venture Capital

    Anaeropharma Science Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Tetsuya MishimaChief Executive Officer, President and Director
    Yuji Yamada Ph.DDirector
    Shun'ichiro Taniguchi Ph.DCo-Founder, Medical and Scientific Advisor
    Nobutake MoriiDirector
    Takehiko SawabeDirector
    Tetsuya Mishima Chief Executive Officer, President and Director
    Yuji Yamada Ph.D Director
    Shun'ichiro Taniguchi Ph.D Co-Founder, Medical and Scientific Advisor
    Nobutake Morii Director
    Takehiko Sawabe Director

    Anaeropharma Science Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Eric de La Fortelle Ph.DSeventure PartnersVenture Partner000 0000
    Minoru Fujimori Ph.DAnaeropharma ScienceCo-Founder & Director000 0000
    Tetsuya MishimaAnaeropharma ScienceChief Executive Officer, President and Director000 0000
    Eric de La Fortelle Ph.D Venture Partner Seventure Partners
    Minoru Fujimori Ph.D Co-Founder & Director Anaeropharma Science
    Tetsuya Mishima Chief Executive Officer, President and Director Anaeropharma Science
    Request full access to PitchBook